Anti-AKR1B1 monoclonal antibody

Pre-made anti-AKR1B1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to AKR1B1/AKR1B1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T26623-Ab-1/ GM-Tg-hg-T26623-Ab-2Anti-Human AKR1B1 monoclonal antibodyHuman
GM-Tg-rg-T26623-Ab-1/ GM-Tg-rg-T26623-Ab-2Anti-Rat AKR1B1 monoclonal antibodyRat
GM-Tg-mg-T26623-Ab-1/ GM-Tg-mg-T26623-Ab-2Anti-Mouse AKR1B1 monoclonal antibodyMouse
GM-Tg-cynog-T26623-Ab-1/ GM-Tg-cynog-T26623-Ab-2Anti-Cynomolgus/ Rhesus macaque AKR1B1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T26623-Ab-1/ GM-Tg-felg-T26623-Ab-2Anti-Feline AKR1B1 monoclonal antibodyFeline
GM-Tg-cang-T26623-Ab-1/ GM-Tg-cang-T26623-Ab-2Anti-Canine AKR1B1 monoclonal antibodyCanine
GM-Tg-bovg-T26623-Ab-1/ GM-Tg-bovg-T26623-Ab-2Anti-Bovine AKR1B1 monoclonal antibodyBovine
GM-Tg-equg-T26623-Ab-1/ GM-Tg-equg-T26623-Ab-2Anti-Equine AKR1B1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T26623-Ab-1/ GM-Tg-hg-T26623-Ab-2; GM-Tg-rg-T26623-Ab-1/ GM-Tg-rg-T26623-Ab-2;
GM-Tg-mg-T26623-Ab-1/ GM-Tg-mg-T26623-Ab-2; GM-Tg-cynog-T26623-Ab-1/ GM-Tg-cynog-T26623-Ab-2;
GM-Tg-felg-T26623-Ab-1/ GM-Tg-felg-T26623-Ab-2; GM-Tg-cang-T26623-Ab-1/ GM-Tg-cang-T26623-Ab-2;
GM-Tg-bovg-T26623-Ab-1/ GM-Tg-bovg-T26623-Ab-2; GM-Tg-equg-T26623-Ab-1/ GM-Tg-equg-T26623-Ab-2
Products NameAnti-AKR1B1 monoclonal antibody
Formatmab
Target NameAKR1B1
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-AKR1B1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T26623-Ag-1Recombinant multi-species ALDR/ AKR1B1/ ADR protein
    ORF Viral VectorpGMLP000471human AKR1B1 Lentivirus plasmid
    ORF Viral VectorpGMAP000366Human AKR1B1 Adenovirus plasmid
    ORF Viral VectorvGMAP000366Human AKR1B1 Adenovirus particle
    ORF Viral VectorvGMLP000471human AKR1B1 Lentivirus particle
    ORF Viral VectorpGMLPm000822mouse Akr1b3 Lentivirus plasmid
    ORF Viral VectorvGMLPm000822mouse Akr1b3 Lentivirus particle


    Target information

    Target IDGM-T26623
    Target NameAKR1B1
    Gene ID231,11677,607537,101095406,100065145
    Gene Symbol and SynonymsADR,Ahr-1,Ahr1,AKR1B1,Akr1b3,Aldor1,ALDR1,ALR2,AR
    Uniprot AccessionP15121
    Uniprot Entry NameALDR_HUMAN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseBreast Cancer
    Gene EnsemblENSG00000085662
    Target ClassificationN/A

    The target: AKR1B1, gene name: AKR1B1, also named as ADR, ALDR1, ALR2, AR. This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. This member catalyzes the reduction of a number of aldehydes, including the aldehyde form of glucose, and is thereby implicated in the development of diabetic complications by catalyzing the reduction of glucose to sorbitol. Multiple pseudogenes have been identified for this gene. The nomenclature system used by the HUGO Gene Nomenclature Committee to define human aldo-keto reductase family members is known to differ from that used by the Mouse Genome Informatics database. [provided by RefSeq, Feb 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.